# ZIVO BIOSCIENCE INC (ZIVOW)

> Institutional ownership reported to the SEC as of Q3 2023, from Form 13F filings. Source: https://holderbook.com/stocks/ZIVOW/

- Reporting holders: 6
- Reported value: $86.8K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Warberg Asset Management LLC](https://holderbook.com/funds/1597506-warberg-asset-management-llc/) | $45.2K | 100,975 | 0.0% | 10 |
| [Ayrton Capital LLC](https://holderbook.com/funds/1698148-ayrton-capital-llc/) | $21.9K | 48,850 | 0.1% | 8 |
| [CITADEL ADVISORS LLC](https://holderbook.com/funds/1423053-citadel-advisors-llc/) | $8.0K | 17,798 | 0.0% | 2 |
| [CVI Holdings, LLC](https://holderbook.com/funds/1728194-cvi-holdings-llc/) | $7.2K | 16,108 | 0.0% | 10 |
| [Verdence Capital Advisors LLC](https://holderbook.com/funds/1719305-verdence-capital-advisors-llc/) | $4.5K | 10,000 | 0.0% | 9 |
| [UBS Group AG](https://holderbook.com/funds/1610520-ubs-group-ag/) | $13 | 30 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2023 | 6 | $86.8K |
| Q2 2023 | 5 | $112.9K |
| Q1 2023 | 4 | $109.1K |
| Q4 2022 | 4 | $43.3K |
| Q3 2022 | 5 | $99.0K |
| Q2 2022 | 5 | $62.0K |
| Q1 2022 | 5 | $66.0K |
| Q4 2021 | 5 | $89.0K |
| Q3 2021 | 4 | $68.0K |
| Q2 2021 | 3 | $118.0K |